Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies

  • Ramin Radmanesh Pharm D., PhD candidate of Pharmacoeconomics and Pharmaceutical Administration, Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Abbas Kebriaeezadeh Pharm D., PhD. Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Keywords: Commercialization, Technology commercialization, Knowledge-based Companies.

Abstract

Background: Looking at the performance of the Iranian knowledge based pharmaceutical companies in recent years shows that, despite extensive capabilities in technologicaldevelopment, many companies involved in technology commercialization have been unsuccessful. Studies show that many components have played role in success or failureof technology commercialization in such companies. This study attempts to identify, and measure the impact of factors affecting technology commercialization in knowledgebased pharmaceutical companies, and provides recommendations and considerations for active managers in this field. Methods: In this survey, questionnaires weredistributed among 10 knowledge based pharmaceutical companies with 19 commercial products. The data were collected, and analyzed to rank the factors based onimportance. Results: Support of senior management, organizational and operational characteristics, extraction of new product concepts, forming risk-taking team and projectmanagement, have the greatest impact on technology commercialization in these companies. Conclusions: Based on the study results, adequate attention to these elementsby the managers of knowledge based companies can lead to success in technology commercialization actions in knowledge based pharmaceutical companies.

References

(1) Mousai MH. Designing a Model to Identify Opportunity and Their

Commercialization in Research and Development and Development

of Technology. JOTMI Research Group.1378 14(4) 15.

(2) Lux D, Rorke M. From Invention to Innovation. Produced for the U.S.

Department of Energy.1999. DOE/GO-10099-810. Retrieved August

, 2008 from http://www1.eere.energy.gov/inventions/pdfs/

fromi2i.pdf

(3) Markham K. Product champions: Crossing the valley of death.

Belliveau P, Griffin A, Somermeyer SM the PDMA Tool book for New

Product Development. 2004. 119-140.

(4) Bandarian R. From Idea to Market in RIPI; an agile Frame for NTD

Process. Journal of Technology Management and Innovation. 2007

(1).

(5) Hogan JE. New product success: Enhance your new product

development process with value gates. http://www.

strategicpricinggroup.com/pdfs/new_product_success.pdf

(Accessed 26/5/2014).

(6) Kotler P. Marketing Management: Analysis, Planning, Implementation,

and Control. 1994, Prentice Hall 8th ed. Englewood Cliffs, New Jersey.

(7) Lemmetyinen J. Commercialization of Biopharmaceuticals, Master’s

thesis submitted in partial fulfillment of the requirements for the

degree of Master of Science in Economics, Lappeenranta University

of Technology, Helsinki; 2001.

Published
2015-10-11
How to Cite
1.
Radmanesh R, Kebriaeezadeh A. Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies. JPPM. 1(3/4):65-8.
Section
Articles